Stockholm - Free Realtime Quote SEK

Vivesto AB (VIVE.ST)

Compare
0.2700
+0.0050
+(1.89%)
As of 10:47:51 AM GMT+1. Market Open.
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
4/30/2020
Total Revenue
--
--
1,015.0000
26,192.0000
201,843.0000
Cost of Revenue
--
--
11,671.0000
44,122.0000
-14,002.0000
Gross Profit
--
--
-10,656.0000
-17,930.0000
215,845.0000
Operating Expense
102,669.0000
138,808.0000
347,066.0000
113,590.0000
246,254.0000
Operating Income
-102,669.0000
-138,808.0000
-357,722.0000
-131,520.0000
-30,409.0000
Net Non Operating Interest Income Expense
-1,129.0000
5.0000
-19.0000
-5,136.0000
-10,962.0000
Pretax Income
-93,403.0000
-128,740.0000
-356,612.0000
-132,722.0000
-43,356.0000
Tax Provision
--
--
--
--
-32,822.0000
Net Income Common Stockholders
-93,403.0000
-128,740.0000
-356,612.0000
-132,722.0000
-10,533.0000
Diluted NI Available to Com Stockholders
-93,403.0000
-128,740.0000
-356,612.0000
-132,722.0000
-10,533.0000
Basic EPS
-0.17
-0.24
-0.72
-0.30
-0.03
Diluted EPS
-0.17
-0.24
-0.72
-0.30
-0.03
Basic Average Shares
538,043.0000
538,043.0000
493,207.0000
448,370.0000
398,395.0000
Diluted Average Shares
538,043.0000
538,043.0000
493,207.0000
448,370.0000
398,395.0000
Total Operating Income as Reported
-95,902.0000
-132,171.0000
-355,397.0000
-128,647.0000
-30,086.0000
Total Expenses
102,669.0000
138,808.0000
358,737.0000
157,712.0000
232,252.0000
Net Income from Continuing & Discontinued Operation
-93,403.0000
-128,740.0000
-356,612.0000
-132,722.0000
-10,533.0000
Normalized Income
-97,757.0000
-132,973.0000
-355,301.0000
-132,802.0000
-9,809.8800
Interest Income
-1,360.0000
5.0000
20.0000
1,167.0000
1,151.0000
Interest Expense
-231.0000
--
39.0000
6,303.0000
10,880.0000
Net Interest Income
-1,129.0000
5.0000
-19.0000
-5,136.0000
-10,962.0000
EBIT
-93,634.0000
-128,740.0000
-356,573.0000
-126,419.0000
-32,476.0000
EBITDA
-42,327.0000
-71,366.0000
-104,279.0000
-97,542.0000
-12,419.0000
Reconciled Cost of Revenue
--
--
11,671.0000
44,122.0000
-14,002.0000
Reconciled Depreciation
51,307.0000
57,374.0000
252,294.0000
28,877.0000
20,057.0000
Net Income from Continuing Operation Net Minority Interest
-93,403.0000
-128,740.0000
-356,612.0000
-132,722.0000
-10,533.0000
Total Unusual Items Excluding Goodwill
4,354.0000
4,233.0000
-1,311.0000
80.0000
-920.0000
Total Unusual Items
4,354.0000
4,233.0000
-1,311.0000
80.0000
-920.0000
Normalized EBITDA
-46,681.0000
-75,599.0000
-102,968.0000
-97,622.0000
-11,499.0000
Tax Rate for Calcs
--
--
--
--
0.0002
Tax Effect of Unusual Items
--
--
--
--
-196.8800
4/30/2020 - 6/24/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PHO.OL Photocure ASA
56.30
-0.71%
 
KLAR.ST Klaria Pharma Holding AB (publ.)
0.6240
-6.87%
 
NANEXA.ST Nanexa AB (publ)
2.1900
0.00%
 
ETST Earth Science Tech, Inc.
0.1500
-6.25%
 
IXHL Incannex Healthcare Inc.
1.8000
-2.17%
 
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.8999
+3.97%
 
SXTC China SXT Pharmaceuticals, Inc.
0.4220
-12.08%
 
ZYBT Zhengye Biotechnology Holding Limited
4.4700
-4.69%
 
UPC Universe Pharmaceuticals INC
0.5200
-15.72%
 
AKAN Akanda Corp.
1.6300
+4.49%